Kymera Therapeutics
KYMR
#3504
Rank
NZ$5.27 B
Marketcap
$81.46
Share price
3.80%
Change (1 day)
239.26%
Change (1 year)

P/S ratio for Kymera Therapeutics (KYMR)

P/S ratio as of November 2024 (TTM): 35.8

According to Kymera Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.51. At the end of 2024 the company had a P/S ratio of 35.9.

P/S ratio history for Kymera Therapeutics from 2020 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202435.999.79%
202318.0-38.54%
202229.2-34.72%
202144.8-44.69%
202081.0

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA